A decision on whether to fund HIV prevention treatment on the NHS should be based on the evidence, not politics.
UK drug funding framework needs an overhaul to ensure the right areas are being prioritisedSubscription
If the NHS is to get value for money from medicines, it needs to consider what the UK population values and where its priorities lie.
In light of the government’s intention to cut funding for the sector and reform the remuneration structure, we asked four people from four different community pharmacy backgrounds to share their views.
Pharmacists and healthcare professionals who are undertaking research should have an understanding of how to produce a research article for publication, and should be aware of the important considerations relating to submission to a peer-reviewed journal.
Patients are more likely to open up and disclose information if they trust their pharmacist or healthcare professional, and a better quality of interaction may result in greater patient autonomy and shared decision-making.
Pharmacist Ana Martinez explains how involving pharmacists in HIV clinical trials earned her the highest honour from the International Pharmaceutical Federation.
The media is a highly competitive industry and perhaps one that most pharmacists would not have considered exploring as a career option. However, there are many pharmacists who work in publishing.
Presenting live television to a global audience in two different languages every morning is a positive stress, says Bav Heer.
Patients with atherosclerotic cardiovascular disease receiving high-intensity statins — including those aged over 75 years — have a lower risk of death than those on a lower-intensity statin, according to new research.
NHS England has the power to fund a ‘game changing’ drug that can prevent HIV infection, the UK Court of Appeal has ruled.
An integrated medicines management service may reduce the number of patients readmitted to hospital with a preventable drug-related problem.
Asthma inhalers being produced in an “increasing array” of colours is unsafe and could put patients lives at risk, say researchers, who have called for an official colour-coding system to avoid confusion.
It would cost between US$1 and US$2 per person per month to ensure those living in a low-to-middle income country have access to the World Health Organization’s (WHO) list of 201 essential medicines, according to a landmark report.
Representatives of employee pharmacists and community pharmacy owners are divided over plans by the pharmacy regulator in Great Britain to reform continuing professional development requirements.
News in Brief
Producers of homeopathic treatments sold over the counter (OTC) in the United States must state on their labels and marketing materials that the products do not work or provide evidence of efficacy for any claims made, a US government agency says.
Despite acknowledging the importance of self-care, many people say a pharmacy would not be their first port of call for advice on treating minor conditions, such as coughs and colds, a report from the Proprietary Association of Great Britain (PAGB) found.
A total of 2 billion people worldwide cannot get the medicines they need despite “moderate progress” by industry to improve access over the past two years, according to the latest Access to Medicine Index.
An influential group of cross-party MPs has launched an inquiry into the impact of the government’s decision to cut community pharmacy funding in England.
A short animation about the value of reporting drug side effects is being used as part of a social media campaign by the UK’s drug safety watchdog.
A new public health bill for Wales — which, if passed, will require health boards to produce pharmaceutical needs assessments (PNAs) — was laid before the Welsh Assembly on 7 November 2016.
Government cuts to community pharmacy funding could significantly add to the winter pressures facing the NHS, according to a survey carried out by the National Pharmacy Association, a trade association for independent community pharmacies in the UK.
NHS England has insufficient expertise and understanding of community pharmacy services and this must be rectified because taking decisions “in ignorance of how community pharmacy props up and supports the NHS is dangerous”, local pharmaceutical committees (LPCs) agreed unanimously at their annual conference.
A ‘hard Brexit’ could threaten the success of the UK life sciences industry and restrict access to new medicines, a think tank has warned.
Let us make research our highest prioritySubscription